Article

FDA Panel Says Yes to HIV Prevention Pill

An anti-HIV combination pill should be approved to prevent HIV infection in healthy people, an FDA advisory committee agreed overwhelmingly Thursday.

The combination of emtricitabine and tenofovir (Truvada) is safe and well tolerated, the committee decided, and helps prevent HIV infection when used daily by people at high risk.

The panel voted 19-3 that a risk-benefit analysis favored approval of the drug for men who have sex with men, and 19-2, with one abstention, for heterosexuals in couples in which one partner has HIV and the other does not.

Read the full story: http://hcp.lv/K2EONW

Source: MedPage Today

Related Videos
Benjamin Chen, MD, PhD
Benjamin Chen, MD, PhD
Lynae Darbes, PhD
Bridgette Picou, LVN, ACLPN, The Well Project
Lynae Darbes, PhD
Katrina Ortblad, ScD, MPH, Fred Hutch Cancer Center
Annie Antar, MD, PhD, Johns Hopkins Medicine
Annie Antar, MD, PhD, Johns Hopkins Medicine
Jared Baeten
Jared Baeten
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo